Table 3 Segmented regression analysis on the monthly ACEIs prescription proportion in the 13 UK regions
Regions | β1(a) | β2(b) | β3(c) | β4(d) | β5(e) | β6(f) | β7(g) |
|---|---|---|---|---|---|---|---|
High baseline ACEIs prescription proportion (>74 %) | |||||||
North East | −0.12 (−0.13, −0.11) | --- | --- | --- | 0.04 (0.02, 0.06) | --- | --- |
South East | −0.06 (−0.70, −0.05) | −0.31 (−0.7, −0.07) | 0.02 (0.01, 0.04) | --- | --- | --- | --- |
Wales | --- | --- | --- | --- | --- | --- | --- |
East Midlands | −0.03 (−0.04, −0.16) | --- | --- | −0.64 (−1.1, −0.20) | 0.16 (0.13, 0.19) | --- | --- |
Intermediate baseline ACEIs prescription proportion (65 %-74 %) | |||||||
Yorkshire and the Humber | −0.08 (−0.09, −0.06) | --- | 0.20 (0.14, 0.24) | −1.80 (−0.26,-0.9) | --- | --- | --- |
East of England | −0.08 (−0.70, −0.05) | −0.40 (−0.7, −0.05) | 0.02 (0.04, 0.03) | --- | --- | --- | --- |
South Central | −0.01 (−0.2, −0.002) | −0.60 (−0.9, −0.40) | --- | −0.47 (−0.7, −0.20) | --- | --- | --- |
Scotland | --- | --- | 0.06 (0.04, 0.08) | −0.49 (−0.80, −0.10) | --- | --- | --- |
West Midlands | --- | --- | −0.03 (−0.04, −0.02) | --- | --- | --- | --- |
North West | 0.01 (0.02, 0.018) | −0.57 (−0.8, −0.33) | 0.04 (0.03, 0.05) | --- | --- | --- | --- |
London | --- | 0.40 (0.20, 0.60) | --- | --- | 0.04 (0.03, 0.05) | --- | --- |
Low baseline ACEIs prescription proportion (<65 %) | |||||||
South East Coast | 0.013 (0.004, 0.02) | −0.42 (−0.7, −0.20) | −0.02 (−0.03,-0.002) | --- | --- | --- | --- |
Northern Ireland | 0.06 (0.05, 0.08) | --- | --- | --- | 0.06 (0.02, 0.09) | --- | --- |